Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-06-24 16:36 |
Pharming receives positive opinion from European Medicines Agency on Rhucin
|
English | 78.1 KB | ||
| 2010-06-21 08:12 |
Pharming provides update on outstanding shares
|
English | 55.3 KB | ||
| 2010-06-15 08:24 |
Pharming provides background information on recently completed private offering
|
English | 66.2 KB | ||
| 2010-06-03 08:08 |
PHARMING PROVIDES UPDATE ON OUTSTANDING SHARES
|
English | 59.0 KB | ||
| 2010-06-02 16:09 |
Pharming reports On Shareholders Meeting
|
English | 69.0 KB | ||
| 2010-05-28 10:43 |
PHARMING SUCCESSFULLY COMPLETES EQUITY FUNDRAISING OF €12 MILLION
|
English | 78.9 KB | ||
| 2010-05-28 08:28 |
PHARMING LAUNCHES EQUITY OFFERING OF UP TO €12 MILLION - Initial commitments of…
|
English | 92.5 KB | ||
| 2010-05-27 08:40 |
PHARMING INITIATES EQUITY FUNDRAISING
|
English | 73.9 KB | ||
| 2010-05-25 08:29 |
PHARMING SUBMITS D180 RESPONSE FOR RHUCIN MAA TO EMA WITHOUT CLOCK STOP - Final…
|
English | 77.3 KB | ||
| 2010-05-21 08:41 |
PHARMING RECEIVES D180 LIST OF OUTSTANDING ISSUES ON RHUCIN MAA
|
English | 71.0 KB | ||
| 2010-05-17 12:17 |
PHARMING INITIATES DIVESTMENT OF DNAGE
|
English | 102.0 KB | ||
| 2010-05-17 08:24 |
Pharming provides update on outstanding shares
|
English | 67.4 KB | ||
| 2010-04-30 20:13 | English | 580.2 KB | |||
| 2010-04-22 08:40 |
Pharming publishes first quarter 2010 financial report
|
English | 76.6 KB | ||
| 2010-04-22 07:09 | English | 76.6 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
